<DOC>
	<DOC>NCT00695071</DOC>
	<brief_summary>The objective of this clinical trial is to document the steady state pharmacokinetics and safety of a new itraconazole 200 mg film coated tablet.</brief_summary>
	<brief_title>Study to Assess Blood Levels of Itraconazole During a Two-Week Period</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>BMI between 18.0 and 28.0 kg/m2 Good physical and mental health status, determined on the basis of the medical history and a general clinical examination. Vital signs (blood pressure and heart rate) in supine position within the normal range Electrocardiogram (12 lead) considered as normal Nonsmoker. Able to swallow pills If subject is a woman of childbearing potential (WOCBP), must agree to use adequate birth control as defined by the protocol Any disease or physical condition which, in the opinion of the investigator, could impact the pharmacokinetics of the drug History or presence of drug abuse or consumption of alcohol History of sensitivity or allergy to azoles or related drugs Any requirement to be on other drug treatment (except acetaminophen and for WOCBP, hormonal contraceptives) Unsuitable veins for repeated venipuncture. Clinically significant abnormal ECG Nursing mothers and pregnant women, or women of childbearing potential not using adequate contraceptives.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>